Multi-centre, international, non-interventional, prospective survey
To assess after 84 days, on a large scale patient population, the evaluation of ocular surface diseases and the satisfaction of dry eye disease (DED) treatment naïve patients or those who had to switch for tolerance, dissatisfaction or efficacy reasons to Thealoz® Duo.
Study Type
OBSERVATIONAL
Enrollment
310
Non applicable
University of Plymouth
Plymouth, United Kingdom
OSDI
Change from baseline for patient symptoms using the ocular surface disease index (OSDI©) questionnaire at Day 84. The OSDI is assessed on a scale of 0 to 100, with higher scores representing greater disability.
Time frame: 84 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.